BSGM - バイオシグ・テクノロジ―ズ (BioSig Technologies Inc.)

BSGMのニュース

   BioSig''s Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium  2021/08/19 15:00:00 Benzinga
Westport, CT, Aug. 19, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM ) ("BioSig" or the "Company"), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it would participate in the Kansas City Heart Rhythm Symposium, due to take place on August 21-22, 2021 at the Overland Park Convention Center. The Company''s clinical and commercial teams will host product demonstrations that will showcase the latest clinical data and the newest software features of its PURE EP(tm) System, the non-invasive class II device that aims to drive procedural efficiency and efficacy in electrophysiology. The Company''s technology will also be featured in a presentation at the Technology Theater during the Symposium. The presentation titled "PURE EP(tm) - A New Standard in Signal Processing" will be conducted during the sessions beginning at noon on Saturday, August 21, 2021, at the Technology Theatre.
   BioSig Technologies unveils PURE EP 2.0 study results  2021/07/26 19:09:51 Seeking Alpha
   BioSig to Host Conference Call to Unblind Clinical Data Collected with its Signal Processing Technology for Arrhythmia Care  2021/07/12 14:30:00 Intrado Digital Media
Westport, CT, July 12, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (BioSig or the Company), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it would host a call to discuss the recent conclusions of its PURE EP(tm) 2.0 study, which enrolled 51 patients at Texas Cardiac Arrhythmia Institute at St. Davids Medical Center in Austin, TX, Mayo Clinic Florida Campus in Jacksonville, FL and Massachusetts General Hospital in Boston, MA.
   BioSig Announces Closing of Public Offering of Common Stock  2021/07/07 20:10:00 Intrado Digital Media
Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (BioSig or the Company), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the completion of its previously announced underwritten public offering of 2,500,000 shares of its common stock, $0.001 par value per share, at a price to the public of $4.00 per share. The gross proceeds to BioSig from this offering were $10 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by BioSig.
   Mayo Clinic Purchases BioSig''s PURE EP for use at its Phoenix Location  2021/07/06 13:44:12 Benzinga
According to a recently filed 8-k, BioSig Technologies, Inc. (NASDAQ: BSGM ) received a new purchase order from the Mayo Foundation for medical education and research. The institution commenced the evaluation of the PURE EP System in April 2021. Under the terms of the commercial transaction, the Foundation is acquiring the PURE EP System for clinical use at Mayo Clinic Phoenix Campus in Arizona. Previously, the institution acquired multiple PURE EP Systems for its Florida and Minnesota Mayo Clinic campuses. To date, more than 1,000 patient cases have been conducted using the PURE EP System by 52 physicians across nine clinical sites. The company is excited about the new sale to the Mayo Clinic and is confident that this denotes the efficacy and potential of its technologies. In fact, its not just the Mayo Clinic Full story available on Benzinga.com
   BioSig Announces Closing of Public Offering of Common Stock  2021/07/07 20:10:00 Intrado Digital Media
Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (BioSig or the Company), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the completion of its previously announced underwritten public offering of 2,500,000 shares of its common stock, $0.001 par value per share, at a price to the public of $4.00 per share. The gross proceeds to BioSig from this offering were $10 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by BioSig.
   Mayo Clinic Purchases BioSig''s PURE EP for use at its Phoenix Location  2021/07/06 13:44:12 Benzinga
According to a recently filed 8-k, BioSig Technologies, Inc. (NASDAQ: BSGM ) received a new purchase order from the Mayo Foundation for medical education and research. The institution commenced the evaluation of the PURE EP System in April 2021. Under the terms of the commercial transaction, the Foundation is acquiring the PURE EP System for clinical use at Mayo Clinic Phoenix Campus in Arizona. Previously, the institution acquired multiple PURE EP Systems for its Florida and Minnesota Mayo Clinic campuses. To date, more than 1,000 patient cases have been conducted using the PURE EP System by 52 physicians across nine clinical sites. The company is excited about the new sale to the Mayo Clinic and is confident that this denotes the efficacy and potential of its technologies. In fact, its not just the Mayo Clinic Full story available on Benzinga.com
   Financings for July 2, 2021  2021/07/02 16:00:00 BioWorld
Med-tech firms raising money in public or private financings, including: Biosig Technologies, Nyxoah.
   BioSig Technologies Raises $10M Via Equity Issued At $4/Share  2021/07/02 13:37:27 Benzinga
BioSig Technologies Inc (NASDAQ: BSGM ) has priced its previously announced underwritten public offering of 2.5 million shares at $4.00 per share , representing a discount of 8% from the last close price of $4.35 on Thursday. The gross proceeds will be approximately Full story available on Benzinga.com
   BioSig Announces Pricing of Public Offering of Common Stock  2021/07/02 12:15:00 Intrado Digital Media
Westport, CT, July 02, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (BioSig or the Company), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced pricing of its previously announced underwritten public offering of 2,500,000 shares of its common stock, $0.001 par value per share, at a price to the public of $4.00 per share. The gross proceeds to BioSig from this offering are expected to be approximately $10 million, or approximately $11.5 million if the underwriter exercises its 30-day option to purchase an additional 15% of the number of shares of common stock offered in the public offering in full, before deducting the underwriting discounts and commissions and estimated offering expenses payable by BioSig. The offering is expected to close on July 7, 2021, subject to the satisfaction of customary closing conditions.
   BioSig Technologies under pressure on announcement of common stock public offering  2021/07/01 20:30:13 Seeking Alpha
   BioSig Announces Proposed Public Offering of Common Stock  2021/07/01 20:05:00 Intrado Digital Media
Westport, CT, July 01, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (BioSig or the Company), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it has commenced an underwritten public offering of its common stock. BioSig also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of common stock offered in the public offering. The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
   Proactive news headlines including BioSig Technologies, Mirasol Resources, Canada Silver Cobalt Works and Versus Systems  2021/06/30 18:10:00 Intrado Digital Media
New York , June 30, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:
   BioSig Completes 1,000 Patient Cases and Expects 1,500 more at the end of 2021  2021/06/30 17:36:44 Benzinga
According to recent reports , the global electroceuticals/bioelectric medicine market is currently worth $16.8 billion and is projected to reach $21.5 billion by 2026, at a compound annual growth rate (CAGR) of 5.0% BioSig Technologies, Inc. (NASDAQ: BSGM ), a medical technology company, unlocks the future of bioelectronic medicine with its PURE EP System. The company recently increased its procedural volume targets to 15,000 due to accelerated technology usage, after delivering 425 procedures at the end of 2020. Today it announced physicians completed 1,000 patient cases. We are thrilled to cross the 1,000-case milestone, a figure that was our initial target for the entire 2021, said Kenneth L. Londoner, chairman and CEO of BioSig Technologies. Most importantly, this case Full story available on Benzinga.com
   BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology - Stocks News Feed  2021/06/30 14:03:32 Stocks News Feed
The Company recently increased its procedural volume targets due to accelerated technology usage BioSig expands its commercial team to target technology adoption across three strategic regions Westport, CT, June 30, 2021 /GLOBE NEWSWIRE/ BioSig Technologies, Inc. (NASDAQ: BSGM) (BioSig or the Company), a medical technology company commercializing an innovative biomedical signal processing platform designed to Read More »BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology

calendar